Francis Spinale to Receptors, Tumor Necrosis Factor, Type II
This is a "connection" page, showing publications Francis Spinale has written about Receptors, Tumor Necrosis Factor, Type II.
Connection Strength
0.625
-
Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial. Heart Rhythm. 2019 05; 16(5):743-753.
Score: 0.625